TrianglePUBLICATIONS · 38959480
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2024 Jul 4
- First author
- Vergote I
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Vergote I
- type
- Author
- name
- González-Martín A
- type
- Author
- name
- Fujiwara K
- type
- Author
- name
- Kalbacher E
- type
- Author
- name
- Bagaméri A
- type
- Author
- name
- Ghamande S
- type
- Author
- name
- Lee JY
- type
- Author
- name
- Banerjee S
- type
- Author
- name
- Maluf FC
- type
- Author
- name
- Lorusso D
- type
- Author
- name
- Yonemori K
- type
- Author
- name
- Van Nieuwenhuysen E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Vergote I
- type
- Author
- name
- González-Martín A
- type
- Author
- name
- Fujiwara K
- type
- Author
- name
- Kalbacher E
- type
- Author
- name
- Bagaméri A
- type
- Author
- name
- Ghamande S
- type
- Author
- name
- Lee JY
- type
- Author
- name
- Banerjee S
- type
- Author
- name
- Maluf FC
- type
- Author
- name
- Lorusso D
- type
- Author
- name
- Yonemori K
- type
- Author
- name
- Van Nieuwenhuysen E
- type
- Author
- bibliography ids
- nci-bib-72b05b6c3eeddf3b1dfc8cfc
- book metadata
- content sha256
- 259ad7669f09a8bb86ade601568d28a52829c6631c7848586c1584460938dcfb
- document type
- citation
- dois
- 10.1056/NEJMoa2313811
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38959480
- immutable id
- pubmed:38959480@259ad7669f09a8bb86ade601568d28a52829c6631c7848586c1584460938dcfb
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 1
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 44-55
- volume
- 391
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38959480
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- b1976d55eb1b09e0003a44c7268c56183777ee001d5ea1f44c57d126c5a3eef5
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Jul 4
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Randomized Controlled Trial
- Clinical Trial, Phase III
- Multicenter Study
- Comparative Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Preserved source evidence · Not medical advice